The FDA approved a new immunization against RSV for all babies entering their first RSV season. Babies entering their second RSV season may also be eligible if they have certain risk factors.
In this video, learn why this new RSV antibody product is so important and how it’s different from most vaccines, according to Preeti Parikh, MD, Executive Medical Director at GoodRx.
Preeti Parikh, MD is the Executive Medical Director at GoodRx and served as the Chief Medical Officer of HealthiNation.
References
Centers for Disease Control and Prevention. (2024). RSV in infants and young children.
FDA Access Data. (2023). BEYFORTUS (package insert).
U.S. Food and Drug Administration. (2023). FDA approves new drug to prevent RSV in babies and toddlers.
Why trust our experts?
Written by:
Lauren Smith, MALauren Smith, MA, has worked in health journalism since 2017. Before joining GoodRx, she was the senior health editor and writer for HealthiNation.
Reviewed by:
Brian Clista, MDDr. Clista is a board-certified pediatrician who works in private practice in Pittsburgh, Pennsylvania. He previously served as a National Health Service Corporation Scholar in the inner city of Pittsburgh for 11 years.
